Publications by authors named "Steffen Bayerschmidt"

Claim this Profile
D
Diagnostic Performance of the Ga-Labeled Minigastrin Analog DOTA-MGS5 in Patients with Advanced Medullary Thyroid Cancer and Other Neuroendocrine Tumors.
Christian Uprimny, Elisabeth von Guggenberg, Anna Sviridenko, Steffen Bayerschmidt, Lisa Maria Rossetti

J Nucl Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Biodistribution, and Radiation Dosimetry of the Ga-Labeled Minigastrin Analog DOTA-MGS5 in Patients with Advanced Medullary Thyroid Cancer and Other Neuroendocrine Tumors.
Elisabeth von Guggenberg, Gianpaolo di Santo, Christian Uprimny, Steffen Bayerschmidt, Boris Warwitz

J Nucl Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of rechallenge with [Lu]Lu-PSMA-I&T radioligand therapy in metastatic castration resistant prostate cancer.
Giulia Santo, Gianpaolo Di Santo, Anna Sviridenko, Steffen Bayerschmidt, Lukas Wirth

Eur J Nucl Med Mol Imaging· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preliminary Clinical Experience with Cholecystokinin-2 Receptor PET/CT Using the Ga-Labeled Minigastrin Analog DOTA-MGS5 in Patients with Medullary Thyroid Cancer.
Elisabeth von Guggenberg, Christian Uprimny, Maximilian Klinger, Boris Warwitz, Anna Sviridenko, Steffen Bayerschmidt

J Nucl Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nephrotoxicity and hematotoxicity one year after four cycles of peptide receptor radionuclide therapy (PRRT) and its impact on future treatment planning - A retrospective analysis.
Bernhard Nilica, Anna Svirydenka, Josef Fritz, Steffen Bayerschmidt, Alexander Kroiss

Rev Esp Med Nucl Imagen Mol (Engl Ed)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Injection of Furosemide Increases Detection Rate of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for Ga-PSMA-11 PET/CT.
Christian Uprimny, Steffen Bayerschmidt, Alexander Stephan Kroiss, Josef Fritz, Bernhard Nilica

J Nucl Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Early Imaging and Imaging 60 min Post-Injection after Forced Diuresis with Furosemide in the Assessment of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for 68Ga-PSMA-11 PET/CT.
Steffen Bayerschmidt, Christian Uprimny, Alexander Stephan Kroiss, Josef Fritz, Bernhard Nilica

Diagnostics (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of forced diuresis with furosemide and hydration on the halo artefact and intensity of tracer accumulation in the urinary bladder and kidneys on [Ga]Ga-PSMA-11-PET/CT in the evaluation of prostate cancer patients.
Christian Uprimny, Steffen Bayerschmidt, Alexander Stephan Kroiss, Josef Fritz, Bernhard Nilica

Eur J Nucl Med Mol Imaging· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis